Le Congrès Pharmaceutique National 2011
National Pharmaceutical Congress 2011 - Wednesday, March 30, 2011 Toscana Conference Centre, Vaughan, Ont.
Conference Title: 11 STRATEGIES FOR A FASTER SMARTER PHARMA

Registration, Continental Breakfast 6:45-8:00


RAPID-FIRE SESSION 1 8:00-9:00
Moderator, David Renwick, Director, Pangaea Group
Introduction: David Renwick, Session Chair and Conference Co-chair (touchpad questions) 8:00-8:05

1. Russell Williams, President, Rx &D 8:05-8:15
Presentation title: Key Issues that keep Rx&D members awake
2. Peter Brenders, President & CEO, BIOTECanada 8:15-8:25
Presentation title: Key Issues that keep BIOTECanada members awake
3. Morris Goodman, Chairman of the Board, Pharmascience Inc. 8:25-8:35
Presentation title: Key issues that keep the Canadian Generic Association members awake
4. David Skinner, President, Consumer Health Products Canada 8:35-8:45
Presentation title: Key issues that keep Consumer Health Product leaders awake
Audience Interaction 8:45-9:00

OXFORD DEBATE I 9:00-9:20
Resolved: This house supports the establishment of the “National Center for Advancing Translational Sciences”, funded by the US Government, to speed the development of new drugs by conducting early-stage research that the pharmaceutical industry is unable or unwilling to perform.
Moderator: Dr. Shafiq Qaadri, MPP
Moderator: Touchpad Voting
For the affirmative: Mark McElwain, kbs+p (Toronto) 5 mins.
For the negative: Jill Donahue, Excellerate (Toronto) 5 mins
Rebuttals (90 seconds each)
Moderator: (2nd audience touchpad vote, and resolution)
Audience Interaction

Nutritional Break, Networking 9:20-9:40

RAPID-FIRE SESSION 2 9:40-10:35
Moderator: Michael Brogan (IMS Brogan, Montreal) 9:40-9:45

1. Brian Jahns, Director of Hematology Business Unit, Hoffmann-La Roche Limited 9:45-9:55
Presentation title: It's Not an Option: Customer Centricity is the Future
2. Andreas Seiger, Marketing Director, Diabetes Care - Novo Nordisk Canada Inc. 9:55-10:00
Presentation title: Lifecycle Management & Forecasting
3. Doug Grant, Head, Corporate Affairs, Bayer Healthcare 10:00-10:10
Presentation title: The Challenge of Reimbursement
4. Kevin Leshuk, General Manager, Celgene Inc. 10:10-10:20
Presentation title: The Tantalus Paradigm
Audience Interaction 10:20-10:25

OXFORD DEBATE II 10:25-10:45
Resolved: This house believes corporate intellectual property rights and worldwide human health initiatives must always be mutually exclusive concepts
Introduction: 3 mins.
Moderator, Dr. Shafiq Qaadri, MPP Touchpad Voting
For the affirmative: Eileen McMahon, Torys (Toronto) 5 mins
For the negative: Marc Lalande, Learning Andrago Inc. (Montreal)
Rebuttals (90 seconds each)
Moderator: (2nd audience touchpad vote, and resolution)
Audience Interaction

RAPID-FIRE SESSION 3 10:45-11:45
Introduction: Mitchell Shannon, Chronicle Companies, Session Chair and Conference Co-chair (touchpad questions) 10:45-10:50

1. Pat Forsythe, Neurosciences Business Unit Director, Allergan Inc. 10:50-11:00
Presentation title: Selling Science: Marketing Specialty Care Products
2. Robin Hunter, Vice President, Critical Care, Leo Pharma Inc. 11:00-11:10
Presentation title: Five Tips for a Better, Smarter Pharma
3.Thomas Schlader, General Manager, Valeant Canada Ltd. 11:10-11:20
Presentation title: 11 Strategies to become a faster/smarter pharma- "the Valeant experience".
4.Claude Perron, Vice President & General Manager, Shire Canada Inc. 11:20-11:30
Presentation title: The key learnings of the Adderall XR® suspension and re-instatement of NOC in 2005
5. Michael Tremblay, President, Astellas Pharma Canada Inc. 11:30-11:40
Presentation title: Improving Patient Lives Program
Audience Interaction 11:40-11:45

Concluding remarks and conference summary: 11:45-11:50


Champagne reception to honor the 2011 inductees to the Canadian Healthcare Marketing Hall of Fame 11:50:12:30


CANADIAN HEALTHCARE MARKETING HALL OF FAME GALA LUNCHEON AND INDUCTION CEREMONIES 12:30-2:15